Improved functionality of the vasculature during conventionally fractionated radiation therapy of prostate cancer

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Potiron, Vincent A ^a,b,c   Abderrahmani, Rym ^a,b,c   Cleḿent Colmou, Karen ^a,b,c,d   Marionneau Lambot, Séverine ^e   Oullier, Thibauld ^e   Paris, François ^a,b,c,d   Supiot, Stéphane ^a,b,c,d  

^a Groupe de Recherche Cytokines et Récepteurs en Immuno Cancérologie   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c UMR 6299   (France)

^d UMR INSERM U892 CNRS 6299   (France)

^e Plate forme in vivo   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DESMIN; PROTEIN ZO1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL FUNCTION; CANCER CELL; CANCER RADIOTHERAPY; CELL DEATH; CELL JUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; HYPOXEMIA; MALE; MOUSE; NONHUMAN; PROSTATE CANCER; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; REOXYGENATION; TISSUE PERFUSION; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

ANIMALS; APOPTOSIS; CELL HYPOXIA; CELL PROLIFERATION; DOSE FRACTIONATION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOENZYME TECHNIQUES; MALE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84896720515     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084076     Document Type: Article

References (45)

1. Baumann M, Krause M, Hill R (2008) Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer 8: 545-554. (Pubitemid 351881850)
2. Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, et al. (2003) Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300: 1155-1159. (Pubitemid 36583102)
3. Bristow RG, Hill RP (2008) Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer 8: 180-192. (Pubitemid 351301853)
4. Park HJ, Griffin RJ, Hui S, Levitt SH, Song CW (2012) Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS). Radiat Res 177: 311-327.
5. Supiot S, Paris F (2012) [Radiobiology dedicated to endothelium]. Cancer Radiother 16: 11-15.
6. Paris F, Fuks Z, Kang A, Capodieci P, Juan G, et al. (2001) Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science (New York, NY) 293: 293-297. (Pubitemid 32694744)
7. Corre I, Niaudet C, Paris F (2010) Plasma membrane signaling induced by ionizing radiation. Mutat Res 704: 61-67.
8. Chen FH, Chiang CS, Wang CC, Tsai CS, Jung SM, et al. (2009) Radiotherapy decreases vascular density and causes hypoxia with macrophage aggregation in TRAMP-C1 prostate tumors. Clin Cancer Res 15: 1721-1729.
9. Chen FH, Fu SY, Yang YC, Wang CC, Chiang CS, et al. (2013) Combination of Vessel-Targeting Agents and Fractionated Radiation Therapy: The Role of the SDF-1/CXCR4 Pathway. Int J Radiat Oncol Biol Phys.
10. Lan J, Wan XL, Deng L, Xue JX, Wang LS, et al. (2013) Ablative hypofractionated radiotherapy normalizes tumor vasculature in lewis lung carcinoma mice model. Radiat Res 179: 458-464.
11. Moeller BJ, Dreher MR, Rabbani ZN, Schroeder T, Cao Y, et al. (2005) Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity. Cancer Cell 8: 99-110. (Pubitemid 41132739)
12. Fuks Z, Kolesnick R (2005) Engaging the vascular component of the tumor response. Cancer Cell 8: 89-91. (Pubitemid 41132735)
13. Burrell K, Hill RP, Zadeh G (2012) High-resolution in-vivo analysis of normal brain response to cranial irradiation. PLoS One 7: e38366.
14. Bonnaud S, Niaudet C, Pottier G, Gaugler MH, Millour J, et al. (2007) Sphingosine-1-phosphate protects proliferating endothelial cells from ceramide-induced apoptosis but not from DNA damage-induced mitotic death. Cancer Res 67: 1803-1811. (Pubitemid 46389242)
15. Imaizumi N, Monnier Y, Hegi M, Mirimanoff RO, Ruegg C (2010) Radiotherapy suppresses angiogenesis in mice through TGF-betaRI/ALK5-dependent inhibition of endothelial cell sprouting. PLoS One 5: e11084.
16. Graves EE, Vilalta M, Cecic IK, Erler JT, Tran PT, et al. (2010) Hypoxia in models of lung cancer: implications for targeted therapeutics. Clin Cancer Res 16: 4843-4852.
17. Penet MF, Pathak AP, Raman V, Ballesteros P, Artemov D, et al. (2009) Noninvasive multiparametric imaging of metastasis-permissive microenvironments in a human prostate cancer xenograft. Cancer Res 69: 8822-8829.
18. Martin JM, Supiot S, Berthold DR (2011) Pharmacotherapeutic management of locally advanced prostate cancer: current status. Drugs 71: 1019-1041.
19. Stewart GD, Ross JA, McLaren DB, Parker CC, Habib FK, et al. (2010) The relevance of a hypoxic tumour microenvironment in prostate cancer. BJU Int 105: 8-13.
20. Milosevic M, Warde P, Menard C, Chung P, Toi A, et al. (2012) Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer. Clin Cancer Res 18: 2108-2114.
21. Bromfield GP, Meng A, Warde P, Bristow RG (2003) Cell death in irradiated prostate epithelial cells: role of apoptotic and clonogenic cell kill. Prostate Cancer Prostatic Dis 6: 73-85. (Pubitemid 36432625)
22. Supiot S, Shubbar S, Fleshner N, Warde P, Hersey K, et al. (2008) A phase I trial of pre-operative radiotherapy for prostate cancer: clinical and translational studies. Radiother Oncol 88: 53-60.
23. Lord EM, Harwell L, Koch CJ (1993) Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. Cancer Res 53: 5721-5726. (Pubitemid 23360277)
24. Winkler F, Kozin SV, Tong RT, Chae SS, Booth MF, et al. (2004) Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 6: 553-563. (Pubitemid 40017699)
25. Armulik A, Genove G, Betsholtz C (2011) Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 21: 193-215.
26. Roe K, Mikalsen LT, van der Kogel AJ, Bussink J, Lyng H, et al. (2012) Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer. Radiat Oncol 7: 75.
27. Maeda A, Leung MK, Conroy L, Chen Y, Bu J, et al. (2012) In vivo optical imaging of tumor and microvascular response to ionizing radiation. PLoS One 7: e42133.
28. Killingsworth MC, Wu X (2011) Vascular pericyte density and angiogenesis associated with adenocarcinoma of the prostate. Pathobiology 78: 24-34.
29. Zovein AC, Luque A, Turlo KA, Hofmann JJ, Yee KM, et al. (2010) Beta1 integrin establishes endothelial cell polarity and arteriolar lumen formation via a Par3-dependent mechanism. Dev Cell 18: 39-51.
30. Gabrys D, Greco O, Patel G, Prise KM, Tozer GM, et al. (2007) Radiation effects on the cytoskeleton of endothelial cells and endothelial monolayer permeability. Int J Radiat Oncol Biol Phys 69: 1553-1562. (Pubitemid 350116438)
31. Bergers G, Song S (2005) The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol 7: 452-464. (Pubitemid 41555617)
32. De Bock K, Cauwenberghs S, Carmeliet P (2011) Vessel abnormalization: another hallmark of cancer? Molecular mechanisms and therapeutic implications. Curr Opin Genet Dev 21: 73-79.
33. Kwak HJ, Lee SJ, Lee YH, Ryu CH, Koh KN, et al. (2000) Angiopoietin-1 inhibits irradiation- and mannitol-induced apoptosis in endothelial cells. Circulation 101: 2317-2324. (Pubitemid 30317136)
34. Yaromina A, Kroeber T, Meinzer A, Boeke S, Thames H, et al. (2011) Exploratory study of the prognostic value of microenvironmental parameters during fractionated irradiation in human squamous cell carcinoma xenografts. Int J Radiat Oncol Biol Phys 80: 1205-1213.
35. Van Putten LM, Kallman RF (1968) Oxygenation status of a transplantable tumor during fractionated radiation therapy. J Natl Cancer Inst 40: 441-451.
36. Brurberg KG, Skogmo HK, Graff BA, Olsen DR, Rofstad EK (2005) Fluctuations in pO2 in poorly and well-oxygenated spontaneous canine tumors before and during fractionated radiation therapy. Radiother Oncol 77: 220-226. (Pubitemid 41682391)
37. Baumann M, Appold S, Zimmer J, Scharf M, Beuthien-Baumann B, et al. (2001) Radiobiological hypoxia, oxygen tension, interstitial fluid pressure and relative viable tumour area in two human squamous cell carcinomas in nude mice during fractionated radiotherapy. Acta Oncol 40: 519-528. (Pubitemid 32682037)
38. Lyng H, Sundfor K, Rofstad EK (2000) Changes in tumor oxygen tension during radiotherapy of uterine cervical cancer: relationships to changes in vascular density, cell density, and frequency of mitosis and apoptosis. Int J Radiat Oncol Biol Phys 46: 935-946. (Pubitemid 30114407)
39. Brizel DM, Dodge RK, Clough RW, Dewhirst MW (1999) Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiother Oncol 53: 113-117.
40. Supiot S, Crehange G, Latorzeff I, Pommier P, Paumier A, et al. (2013) [Hypofractionated radiotherapy in prostate cancer]. Cancer Radiother 17: 349-354.
41. Carlson DJ, Keall PJ, Loo BW,Jr, Chen ZJ, Brown JM (2011) Hypofractionation results in reduced tumor cell kill compared to conventional fractionation for tumors with regions of hypoxia. Int J Radiat Oncol Biol Phys 79: 1188-1195.
42. Zywietz F, Reeker W, Kochs E (1995) Tumor oxygenation in a transplanted rat rhabdomyosarcoma during fractionated irradiation. Int J Radiat Oncol Biol Phys 32: 1391-1400.
43. Laughlin KM, Evans SM, Jenkins WT, Tracy M, Chan CY, et al. (1996) Biodistribution of the nitroimidazole EF5 (2-[2-nitro-1H-imidazol-1-yl]-N-(2,2, 3,3,3-pentafluoropropyl) acetamide) in mice bearing subcutaneous EMT6 tumors. J Pharmacol Exp Ther 277: 1049-1057.
44. Dreher MR, Liu W, Michelich CR, Dewhirst MW, Yuan F, et al. (2006) Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. J Natl Cancer Inst 98: 335-344. (Pubitemid 43338213)
45. Potiron VA, Abderrhamani R, Giang E, Chiavassa S, Di Tomaso E, et al. (2013) Radiosensitization of prostate cancer cells by the dual PI3K/mTOR inhibitor BEZ235 under normoxic and hypoxic conditions. Radiother Oncol 106: 138-146.